LA
Legacy Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,002
| Closed | -$1.5M | – | 365 |
|
|
2025
Q1 | $1.5M | Buy |
3,002
+172
| +6% | +$85.7K | 0.15% | 113 |
|
|
2024
Q4 | $1.47M | Sell |
2,830
-112
| -4% | -$58.3K | 0.14% | 108 |
|
|
2024
Q3 | $1.82M | Buy |
2,942
+88
| +3% | +$54.4K | 0.2% | 91 |
|
|
2024
Q2 | $1.58M | Sell |
2,854
-28
| -1% | -$15.5K | 0.19% | 90 |
|
|
2024
Q1 | $1.68M | Sell |
2,882
-1,654
| -36% | -$962K | 0.21% | 86 |
|
|
2023
Q4 | $2.41M | Sell |
4,536
-1,673
| -27% | -$889K | 0.31% | 69 |
|
|
2023
Q3 | $3.15M | Sell |
6,209
-160
| -3% | -$81K | 0.51% | 48 |
|
|
2023
Q2 | $3.32M | Sell |
6,369
-176
| -3% | -$91.8K | 0.49% | 43 |
|
|
2023
Q1 | $3.77M | Buy |
6,545
+318
| +5% | +$183K | 0.7% | 33 |
|
|
2022
Q4 | $3.43M | Buy |
6,227
+1,159
| +23% | +$639K | 0.63% | 33 |
|
|
2022
Q3 | $2.57M | Buy |
5,068
+668
| +15% | +$339K | 0.57% | 35 |
|
|
2022
Q2 | $2.39M | Buy |
4,400
+682
| +18% | +$371K | 0.5% | 37 |
|
|
2022
Q1 | $2.2M | Buy |
+3,718
| New | +$2.2M | 0.43% | 42 |
|
|
2019
Q2 | – | Sell |
-47
| Closed | -$13K | – | 423 |
|
|
2019
Q1 | $13K | Buy |
+47
| New | +$13K | ﹤0.01% | 314 |
|
|
2018
Q4 | – | Sell |
-47
| Closed | -$11K | – | 366 |
|
|
2018
Q3 | $11K | Hold |
47
| – | – | 0.01% | 342 |
|
|
2018
Q2 | $10K | Hold |
47
| – | – | 0.01% | 307 |
|
|
2018
Q1 | $10K | Hold |
47
| – | – | 0.01% | 270 |
|
|
2017
Q4 | $8K | Sell |
47
-21
| -31% | -$3.57K | 0.01% | 275 |
|
|
2017
Q3 | $12K | Buy |
+68
| New | +$12K | 0.01% | 202 |
|